Company intelligence / Profile preview

Kenota

Kitchener, Ontario, Canadaf6s.com ↗

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Kenota (formerly ExVivo Labs) develops rapid and accessible diagnostic solutions designed to simplify and accelerate disease testing at the point of care. Their technology enables quick results outside traditional laboratory settings using innovative biosensor or microfluidic platforms. The company’s focus is on improving speed and accessibility in infectious disease diagnostics for healthcare providers.

Therapeutic areas: Infectious DiseasesOther
Modalities: DeviceDiagnostic assayBiosensor-based technology
Industry: Molecular Diagnostics

Partnerships

Not publicly disclosed as of June 2025

Beyond the preview

Go deeper on Kenota.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kenota.

Explore the full profile